Cargando…
Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that involves multiple organs and disproportionality affects females, especially African Americans from 15 to 44 years of age. SLE can lead to end organ damage including kidneys, lungs, cardiovascular and neuropsychiatric systems, wi...
Autores principales: | Harden, Olivia C., Hammad, Samar M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546393/ https://www.ncbi.nlm.nih.gov/pubmed/33101319 http://dx.doi.org/10.3389/fimmu.2020.586737 |
Ejemplares similares
-
Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value
por: Hammad, Samar M., et al.
Publicado: (2021) -
The role of organ-deposited IgG in the pathogenesis of multi-organ and tissue damage in systemic lupus erythematosus
por: Qiu, Wenlin, et al.
Publicado: (2022) -
Hyaluronic Acid Synthesis Contributes to Tissue Damage in Systemic Lupus Erythematosus
por: Suarez-Fueyo, Abel, et al.
Publicado: (2019) -
Placental damage in pregnancies with systemic lupus erythematosus: A narrative review
por: Castellanos Gutierrez, Aleida Susana, et al.
Publicado: (2022) -
Editorial: New biomarkers for the diagnosis and treatment of systemic lupus erythematosus
por: Perl, Andras, et al.
Publicado: (2022)